This content is PDF only. Please click on the PDF icon to access.
This Clinical Efficacy Assessment Project report analyzes the safety and efficacy of exercise thallium-201 myocardial perfusion scintigraphy (thallium scintigraphy) in the diagnosis and prognosis of patients with suspected coronary artery disease and documented myocardial infarction.
Thallium scintigraphy is most often done as an adjunct to conventional exercise electrocardiography (ECG) to aid in the diagnosis, prognosis, and functional evaluation of patients with known or suspected coronary artery disease. The patient is given an intravenous dose of thallium-201, ranging from 2.0 to 3.5 mCi, at the peak of exercise. Exercise is continued for an additional 30 to 60 seconds
Learn more about subscription options.
Register Now for a free account.
Efficacy of Exercise Thallium-201 Scintigraphy in the Diagnosis and Prognosis of Coronary Artery Disease. Ann Intern Med. 1990;113:703-704. doi: 10.7326/0003-4819-113-9-703
Download citation file:
Published: Ann Intern Med. 1990;113(9):703-704.
Cardiology, Coronary Heart Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only